| 000 | 01564 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515190748.0 | ||
| 264 | 0 | _c20091116 | |
| 008 | 200911s 0 0 eng d | ||
| 022 | _a1546-170X | ||
| 024 | 7 |
_a10.1038/nm.1990 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOney, Sabah | |
| 245 | 0 | 0 |
_aDevelopment of universal antidotes to control aptamer activity. _h[electronic resource] |
| 260 |
_bNature medicine _cOct 2009 |
||
| 300 |
_a1224-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aAntidotes _xadministration & dosage |
| 650 | 0 | 4 |
_aAptamers, Nucleotide _xclassification |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aFactor IX _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFactor Xa Inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNucleic Acid Conformation _xdrug effects |
| 650 | 0 | 4 |
_aOligonucleotides _xpharmacology |
| 650 | 0 | 4 |
_aProtamines _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLam, Ruby T S | |
| 700 | 1 | _aBompiani, Kristin M | |
| 700 | 1 | _aBlake, Charlene M | |
| 700 | 1 | _aQuick, George | |
| 700 | 1 | _aHeidel, Jeremy D | |
| 700 | 1 | _aLiu, Joanna Yi-Ching | |
| 700 | 1 | _aMack, Brendan C | |
| 700 | 1 | _aDavis, Mark E | |
| 700 | 1 | _aLeong, Kam W | |
| 700 | 1 | _aSullenger, Bruce A | |
| 773 | 0 |
_tNature medicine _gvol. 15 _gno. 10 _gp. 1224-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nm.1990 _zAvailable from publisher's website |
| 999 |
_c19197298 _d19197298 |
||